Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Jul;6(7):528-529.
doi: 10.1016/S2468-1253(21)00184-9. Epub 2021 May 26.

SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change?

James L Alexander  1 , Nick Powell  2 ; British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group
Affiliations
Comment

SARS-CoV-2 vaccination in immunosuppressed patients with inflammatory bowel disease: should our approach change?

James L Alexander et al. Lancet Gastroenterol Hepatol. 2021 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

JLA reports sponsorship from Vifor Pharma for accommodation/travel to BSG 2019, outside the submitted work. NP reports he has served as a speaker for Allergan, Bristol Myers Squibb, Falk, Ferring, Janssen, Pfizer, Tillotts, and Takeda, and as a consultant and/or an advisory board member for AbbVie, Allergan, Celgene, Bristol Myers Squibb, Ferring, and Vifor Pharma.

Comment on

References

    1. Alexander JL, Moran GW, Gaya DR, et al. SARS-CoV-2 vaccination for patients with inflammatory bowel disease: a British Society of Gastroenterology Inflammatory Bowel Disease section and IBD Clinical Research Group position statement. Lancet Gastroenterol Hepatol. 2021;6:218–224. - PMC - PubMed
    1. Pottegard A, Lund LC, Karlstad O, et al. Arterial events, venous thromboembolism, thrombocytopenia, and bleeding after vaccination with Oxford-AstraZeneca ChAdOx1-S in Denmark and Norway: population based cohort study. BMJ. 2021;373 - PMC - PubMed
    1. Miehsler W, Reinisch W, Valic E, et al. Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut. 2004;53:542–548. - PMC - PubMed
    1. Grainge MJ, West J, Card TR. Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet. 2010;375:657–663. - PubMed
    1. MHRA Green book. Chapter 14a. COVID-19 - SARS-CoV-2. https://assets.publishing.service.gov.uk/government/uploads/system/uploa...

Substances